Short- and long-term outcomes following percutaneous coronary intervention in hepatitis C virus seropositive patients.
Ahmed HusseinMohamed Abdel GhanyHossam Eldin M MahmoudPublished in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2020)
HCV seropositivity had no impact on MACEs, individual cardiovascular outcomes, or clinical in-stent restenosis following PCI for a 1 year follow-up period.
Keyphrases
- hepatitis c virus
- percutaneous coronary intervention
- end stage renal disease
- acute myocardial infarction
- coronary artery disease
- acute coronary syndrome
- st segment elevation myocardial infarction
- human immunodeficiency virus
- newly diagnosed
- ejection fraction
- st elevation myocardial infarction
- antiplatelet therapy
- chronic kidney disease
- peritoneal dialysis
- atrial fibrillation
- coronary artery bypass grafting
- prognostic factors
- heart failure
- patient reported outcomes
- hiv infected
- left ventricular
- antiretroviral therapy